Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Scandinavian Real Heart

13.15

 

SEK

 

-0.75 %

Less than 1K followers

HEART

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Compare
-0.75%
-2.59%
+0.38%
+25.12%
+10.88%
-58.65%
-92.4%
-95.47%
-91.51%

Scandinavian Real Heart operates in medical technology. Today, the company's main focus is on research and development of heart pumps used among patients with severe heart conditions who are in the queue for transplant. The idea behind the heart pump is to use the product as a transitional solution before a final heart transplant is performed. The company is based in Västerås.

Read more
Market cap
65.73M SEK
Turnover
292.86K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
28.8.
2025

Interim report Q2'25

13.11.
2025

Interim report Q3'25

All
Press releases
3rd party
ShowingAll content types
Press release7/7/2025, 6:30 AM

Realheart Receives SEK 6.8 Million Following Directed Share Issue to the European Innovation Council

Scandinavian Real Heart
Press release6/27/2025, 1:15 PM

Realheart Changes From Quarterly to Biannual Financial Reporting

Scandinavian Real Heart
Press release6/18/2025, 6:30 AM

Realheart Publishes Validating Data Showing Hemodynamic Balance and Automated Cardiac Output Control

Scandinavian Real Heart

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Press release6/17/2025, 6:30 AM

Realheart Receives Patent Approval in the US

Scandinavian Real Heart
Regulatory press release6/12/2025, 3:35 PM

Bulletin From the Annual General Meeting of Scandinavian Real Heart AB on June 12, 2025

Scandinavian Real Heart
Press release6/10/2025, 9:45 AM

Realheart® TAH Showcased in Public Service Documentary

Scandinavian Real Heart
Regulatory press release5/23/2025, 6:30 AM

Realheart Releases Annual Report for 2024

Scandinavian Real Heart
Regulatory press release5/15/2025, 6:30 AM

Interim Report January – March 2025

Scandinavian Real Heart
Regulatory press release5/12/2025, 11:00 AM

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN SCANDINAVIAN REAL HEART AB

Scandinavian Real Heart
Regulatory press release5/2/2025, 6:12 PM

EIC has Subscribed for 600,000 Shares in the Directed Share Issue Resolved by the Board of Directors of Realheart on 27 April 2025

Scandinavian Real Heart
Press release4/29/2025, 12:32 PM

Realheart Receives Patent Approval in Japan

Scandinavian Real Heart
Regulatory press release4/2/2025, 10:30 AM

Scandianvian Real Heart AB Announces Outcome of Exercise of Warrants of Series TO 3

Scandinavian Real Heart
Regulatory press release3/27/2025, 8:05 PM

Realheart Has Resolved on a Directed Share Issue of a Maximum of 2,881,115 Shares Which Will Provide the Company With Approximately SEK 32.6 Million Upon Full Subscription

Scandinavian Real Heart
Regulatory press release3/27/2025, 4:35 PM

Realheart Announces Intention to Carry out a Directed Share Issue of up to Approximately SEK 32 Million

Scandinavian Real Heart
Regulatory press release3/3/2025, 7:55 PM

Subscription Price Determined for the Exercise of Series TO3 Warrants in Scandinavian Real Heart AB

Scandinavian Real Heart
Regulatory press release2/26/2025, 7:30 AM

Year-End Report Q4, 2024

Scandinavian Real Heart
Regulatory press release2/4/2025, 7:30 AM

Scandinavian Real Heart AB Announces Outcome of the Exercise of Series TO 2 Warrants

Scandinavian Real Heart
Regulatory press release1/30/2025, 12:40 PM

Realheart Presents Successful Results From a Preclinical Implantation Using Its Total Artificial Heart

Scandinavian Real Heart
Regulatory press release1/29/2025, 4:25 PM

Realheart® TAH Receives Humanitarian Use Device Designation by the U.S. Food and Drug Administration (FDA)

Scandinavian Real Heart
Press release1/27/2025, 12:00 PM

Last Day for Exercise of Warrants TO 2 in Scandinavian Real Heart AB

Scandinavian Real Heart
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.